William C. Olson, VP, Research & Development at PROGENICS PHARMACEUTICALS INC (PGNX), sold 14,000 shares at $24.00 ($336K) on 2006-05-04, disclosed to the SEC on 2006-05-08.
Scheduled sale ($336k) by VP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 10,107 | $243K | 72.2% |
| 2 | $24.00 | 3,893 | $93K | 27.8% |
| Total | $24.00 avg | 14,000 | $336K | 100% |
| Filing → |
| PGNX | SELL | 2009-06-24 | $12K | — | Filing → |
| PGNX | SELL | 2007-12-05 | $76K | — | Filing → |
| PGNX | SELL | 2006-06-22 | $22K | — | Filing → |